Yongan Futures' overseas subsidiary has obtained membership qualification for the Abes Exchange.
Everbright Futures (600927.SH) announced that on June 24, 2026, its overseas wholly-owned subsidiary, Everbright International Financial (Singapore) Limited (referred to as "Everbright Singapore"), received a notification from ABAXX Exchange (Asia) that Everbright Singapore will obtain clearing membership qualification on ABAXX Exchange on June 29, 2026. Everbright Singapore can directly engage in derivative trading clearing business with ABAXX Exchange and act as an agent to conduct related clearing business.
Yongan Futures (600927.SH) announced that on June 24, 2026, its wholly-owned subsidiary Yongan International Financial (Singapore) Limited (referred to as "Yongan Singapore") received a notice from the ABAXX Exchange that Yongan Singapore will be granted clearing membership on the ABAXX Exchange on June 29, 2026. This will allow Yongan Singapore to directly engage in derivative trading clearing operations with the ABAXX Exchange and act as an agent to conduct related clearing operations.
Related Articles
Circuit Fabology Microelectronics Equipment (09630): The sale price is set at 252.73 Hong Kong dollars per share.
On June 24, YOUZAN (06051) spent approximately HK$1.1694 million to repurchase 15.536 million shares.
Meiwei Bio (688062.SH): The clinical trial application for 9MW5211 injection has been approved by the National Medical Products Administration.
Circuit Fabology Microelectronics Equipment (09630): The sale price is set at 252.73 Hong Kong dollars per share.
On June 24, YOUZAN (06051) spent approximately HK$1.1694 million to repurchase 15.536 million shares.
Meiwei Bio (688062.SH): The clinical trial application for 9MW5211 injection has been approved by the National Medical Products Administration.
RECOMMEND
